The Gastroenterology Market is a segment of the overall market of healthcare services, which concentrates on the assessment, Prevention, and control of health disorders of the gastrointestinal system.

The genomic cancer testing is one of the emerging stratified market segments within the sphere of oncology diagnostics as a result of the development of genetic technologies and the current tendency to shift from usual or conventional approaches to individualized medicine. Genomic cancer testing is, therefore, a diagnostic test that aims at determining the specific alteration of a gene of a specific cancer patient, their type of cancer and other parameters and possible response to treatment. Genomic testing in cancer therefore offers better understanding of the molecular nature, and leads to better targeted therapies that provide better patient outcomes with lesser toxicity.